Therapeutic interventions in HIV infection - A critical view

Tropical Medicine and International Health

Volumn 5, Issue 7, 2000, Pages

  Darbyshire, Janet ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

ART; HAART; HIV infection; NRTI; PI; Resistance; Therapeutic failure

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE CONTROL; DRUG PRESCRIBING; HUMAN IMMUNODEFICIENCY VIRUS;

CONFERENCE PAPER; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RESOURCE MANAGEMENT; TREATMENT FAILURE;

ADULT; ANTI-HIV AGENTS; CHILD; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT FAILURE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033859928     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2000.00597.x     Document Type: Conference Paper

References (34)

1. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome
2. Variability in trough plasma saquinavir concentrations in HIV patients - A case for therapeutic drug monitoring
3. A pilot study of the short-term effects of antiretroviral management based on plasma genotypic antiretroviral resistance testing (GART) in patients failing antiretroviral therapy
4. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
5. Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society-USA Panel
6. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
7. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
8. Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomised controlled trial
9. IL-2 therapy for HIV disease: A meta-analysis of three randomized, controlled trials
10. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
11. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
12. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
13. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy
14. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: Meta-analyses of the randomised evidence
15. Toward HIV eradication or remission: The tasks ahead
16. Buffalo hump in men with HIV-1 Infection
17. Visceral abdominal fat accumulation associated with the use of indinavir
18. Mega-HAART, resistance and drug holidays
19. Changing patterns of mortality across Europe in patients infected with HIV-1
20. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. The INCAS Trial
21. Declining morbidity and mortality among patients with advanced human immunodeficiency virus refection
22. A randomised trial of three maintenance regimens given after three mouths of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1 infected patients
23. A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection
24. Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the treatment of HIV-1 infection in adults
25. A randomised trial comparing regiments of four reverse transcriptase inhibitors given together or cyclically in HIV-1 infection: The Quattro trial
26. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia